These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2267192)

  • 1. [Assessment of the efficacy of treating infections in hematopoietic proliferative diseases: Monotherapy with ceftazidime and tobramycin combined with amoxycillin/ampicillin].
    Koehler M; Bubała H; Sońta-Jakimczyk D; Wieczorek M; Janik-Moszant A; Kuder K
    Pol Tyg Lek; 1990 May 21-28; 45(21-22):417-20. PubMed ID: 2267192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of imipenem-cilastatin versus ceftazidime plus tobramycin as empiric therapy of presumed bacterial infection in neutropenic cancer patients.
    Miller JA; Butler T; Beveridge RA; Kales AN; Binder RA; Smith LJ; Ueno WM; Milkovich G; Goldwater S; Marion A
    Clin Ther; 1993; 15(3):486-99. PubMed ID: 8364941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftazidime versus tobramycin plus ticarcillin in the treatment of soft-tissue infections.
    Solomkin JS; Cocchetto DM
    Clin Ther; 1986; 9(1):123-34. PubMed ID: 3545476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftazidime/clindamycin versus tobramycin/clindamycin in the treatment of intra-abdominal infections.
    Bubrick MP; Heim-Duthoy KL; Yellin AE; Berne TV; Heseltine PN; Appleman MD; Cocchetto DM; Matzke GR
    Am Surg; 1990 Oct; 56(10):613-7. PubMed ID: 2221611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised dosage study of ceftazidime with single daily tobramycin for the empirical management of febrile neutropenia in patients with hematological diseases.
    Gibson J; Johnson L; Snowdon L; Joshua D; Young G; MacLeod C; Iland H; Vincent P; Kronenberg H
    Int J Hematol; 1994 Aug; 60(2):119-27. PubMed ID: 7948961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftazidime versus ceftazidime plus tobramycin in febrile neutropenic children.
    Jacobs RF; Vats TS; Pappa KA; Chaudhary S; Kletzel M; Becton DL
    Infection; 1993; 21(4):223-8. PubMed ID: 8225625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo efficacy of humanised intermittent versus continuous ceftazidime in combination with tobramycin in an experimental model of pseudomonal pneumonia.
    Croisier D; Martha B; Piroth L; Chavanet P
    Int J Antimicrob Agents; 2008 Dec; 32(6):494-8. PubMed ID: 18804348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of the effectiveness of ceftazidime and cefazolin/tobramycin in patients with inflammatory diseases of the lower respiratory tract].
    Vetter N; Feist H; Armbruster C; Drlicek M
    Infection; 1987; 15 Suppl 4():S192-4. PubMed ID: 3312033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotics in infections of the biliary tract.
    Muller EL; Pitt HA; Thompson JE; Doty JE; Mann LL; Manchester B
    Surg Gynecol Obstet; 1987 Oct; 165(4):285-92. PubMed ID: 3310282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative clinical study of Sulbactam and ampicillin and clindamycin and tobramycin in infections of soft tissues.
    Stromberg BV; Reines HD; Hunt P
    Surg Gynecol Obstet; 1986 Jun; 162(6):575-8. PubMed ID: 3012808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of monotherapy with ceftazidime for severe infections complicating hematological disorders. Hyogo Cooperative Study Group of Infectious Diseases Complicating Hematological Disorders].
    Takemoto Y; Kanamaru A; Nagai K; Hara H; Nakayama S; Himei S; Ikeda T; Iwao N; Tago H; Yamaguchi N
    Rinsho Ketsueki; 1989 Mar; 30(3):316-22. PubMed ID: 2671434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftazidime monotherapy vs. ceftriaxone/tobramycin for serious hospital-acquired gram-negative infections. Antibiotic Study Group.
    Rubinstein E; Lode H; Grassi C
    Clin Infect Dis; 1995 May; 20(5):1217-28. PubMed ID: 7620002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multicenter clinical study and pharmacokinetics of ceftazidime in children and newborn infants].
    Bégué P; Michel B; Chasalette JP; Allouche G; Quinet B
    Pathol Biol (Paris); 1986 May; 34(5):525-9. PubMed ID: 3534737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amikacin plus ceftazidime versus amikacin plus piperacillin versus amikacin plus aztreonam in infections in neoplastic patients with granulocytopenia.
    Casali A; Ameglio F; Gionfra T; Tonachella R; Paoletti G; Gallo Curcio C
    Chemioterapia; 1987 Dec; 6(6):440-4. PubMed ID: 3325175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of the pharmacokinetics of tobramycin administered in a single daily dose or in 3 doses in cystic fibrosis].
    Canis F; Trivier D; Vic P; Ategbo S; Turck D; Husson MO
    Pathol Biol (Paris); 1998 Jun; 46(6):449-51. PubMed ID: 9769880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of febrile episodes in neutropenic children by ceftazidime combined with netilmicin. Results of a multicenter study apropos of 88 cases].
    Leverger G; Demeocq F; Harousseau JL; Taboureau O; Vannier JP; Boilletot A; de Lumley L; Boutard P; Olive D; Reinert P
    Pathol Biol (Paris); 1987 May; 35(5):648-51. PubMed ID: 3302878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of intravenous meropenem and tobramycin versus ceftazidime and tobramycin in cystic fibrosis.
    Latzin P; Fehling M; Bauernfeind A; Reinhardt D; Kappler M; Griese M
    J Cyst Fibros; 2008 Mar; 7(2):142-6. PubMed ID: 17766190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of isepamicin and ceftazidime compared with amikacin and ceftazidime in acute lower respiratory tract infection.
    Colardyn F
    J Chemother; 1995 Jun; 7 Suppl 2():129-35. PubMed ID: 8622101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients.
    Metallidis S; Kollaras P; Giannakakis T; Seitanidis B; Kordosis T; Nikolaidis J; Hatzitolios A; Nikolaidis P
    Eur J Intern Med; 2008 Dec; 19(8):619-24. PubMed ID: 19046729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of ceftazidime and aminoglycoside based regimens as empirical treatment in 1316 cases of suspected sepsis in the newborn. European Society for Paediatric Infectious Diseases--Neonatal Sepsis Study Group.
    de Louvois J; Dagan R; Tessin I
    Eur J Pediatr; 1992 Dec; 151(12):876-84. PubMed ID: 1473540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.